Sign in
8-K

Current Report

Vir Biotechnology, Inc. Filed Acc 0001193125-23-294328

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading d643902d8k.htm…